Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
Abstract Cancer drug screening in patient‐derived cells holds great promise for personalized oncology and drug discovery but lacks standardization. Whether cells are cultured as conventional monolayer or advanced, matrix‐dependent organoid cultures influences drug effects and thereby drug selection...
Saved in:
| Main Authors: | Julia Jabs, Franziska M Zickgraf, Jeongbin Park, Steve Wagner, Xiaoqi Jiang, Katharina Jechow, Kortine Kleinheinz, Umut H Toprak, Marc A Schneider, Michael Meister, Saskia Spaich, Marc Sütterlin, Matthias Schlesner, Andreas Trumpp, Martin Sprick, Roland Eils, Christian Conrad |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2017-11-01
|
| Series: | Molecular Systems Biology |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/msb.20177697 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Harnessing Organoid Platforms for Nanoparticle Drug Development
by: Chen L, et al.
Published: (2025-07-01) -
Multicenter study correlating molecular characteristics and clinical outcomes of cancer cases with patient-derived organoids
by: Paloma Navarro, et al.
Published: (2025-07-01) -
Pancreatic cancer organoids derived from EUS-guided fine needle aspiration specimens can be used to predict chemotherapy resistance
by: Soshi Oyama, et al.
Published: (2025-07-01) -
The Application of Organoid Technology in the Research of Central Nervous System Tumors
by: WANG Zicong, et al.
Published: (2025-07-01) -
Pharmacogenomics Education and Knowledge Assessment in Healthcare Curricula: A Scoping Review of the Middle East and North Africa Region
by: Asmaa Ibrahim, et al.
Published: (2025-08-01)